Effectiveness of empagliflozin in patients with heart failure and COPD: Results from EMPEROR-Preserved and EMPEROR-Reduced

31 August 2024 (10:20 - 10:30)
Organised by: Logo
Congress Presentation Part of: Further Insights into SGLT2i treatment for heart failure Comorbidities ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

ESC 365 is supported by

ESC 365 is supported by